Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01168804 · COMPLETED
Trial details
- NCT number
- NCT01168804
- Sponsor
- Austrian Forum Against Cancer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-05-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.